Source: Eur Respir J , 49 (4)  1700443; DOI: 10.1183/13993003.00443-2017



Rating:

Share or cite this content

Citations should be made in the following way:
Michael Arzt, Danny J. Eckert. Is fluid overload a target to treat sleep disordered breathing in patients with end-stage renal disease, and what are the underlying mechanisms?. Eur Respir J , 49 (4)  1700443; DOI: 10.1183/13993003.00443-2017

Member's Comments

No comment yet.

Related content which might interest you: Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease Source: Eur Respir J 2006; 28: 151-158 Year: 2006 The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Cardiac performance indices and neurohumoral activation in patients with stable chronic heart failure and sleep disordered breathing Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing Year: 2009 Managing deteriorations in chronic obstructive pulmonary disease: which organ is failing? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018 Disturbed sleep and breathing disturbances in COPD and restrictive lung diseases: evidence gaps and challenges in diagnosis and treatment Source: 5th Sleep and Breathing Conference Year: 2019 The link  between dynamic hyperinflation, autonomic dysfunction and exercise testing parameters with masked heart failure  in patients with non-severe obstructive pulmonary disease Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases Year: 2020 Sleep-disordered breathing in the elderly Source: Eur Respir Mon; 2009: 43: 179–204 Year: 2009 Investigating the fatigue and related factors in patients with chronic obstructive pulmonary disease. Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease Year: 2017 The severity of central sleep apnoea syndrome in patients with chronic congestive heart failure is dependent on the quality of medical treatment Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002 Does obstructive sleep apnoea predispose to reduced renal function? Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease? Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 How we can modify the steroid insensitivity in patients with chronic obstructive pulmonary disease? The new pharmacological approach to old problem Source: Annual Congress 2011 - COPD management Year: 2011 Early peripheral muscle structural and metabolic impairment in chronic obstructive pulmonary disease (COPD) patients cannot be considered as a consequence of sedentarity Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers Year: 2011 What is significant sleep disordered breathing in patients with interstitial lung disease? Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 The relationship between autonomic modulation of heart rate variability and sleep breathing disorders in patient with chronic heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 815s Year: 2006 Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Do nocturnal apnoeas contribute to increased cardiovascular risk in end stage renal disease patients? Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Possible mechanisms underlying the development of cachexia in COPD Source: Eur Respir J 2008; 31: 492-501 Year: 2008 What are the common biological mechanisms that lead to obstructive airway disease? Source: International Congress 2016 – Early life origins of asthma and COPD Year: 2016